JMPWA
NKTR icon

JP Morgan Private Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-726
Closed -$187K – 1967
2021
Q2 		$187K Sell
726
-14
-2% -$3.88K ﹤0.01% 1847
2021
Q1 		$222K Sell
740
-33
-4% -$10.3K ﹤0.01% 1643
2020
Q4 		$197K Sell
773
-182
-19% -$47K ﹤0.01% 1651
2020
Q3 		$238K Buy
955
+12
+1% +$3.77K ﹤0.01% 1460
2020
Q2 		$327K Sell
943
-26
-3% -$8.11K ﹤0.01% 1274
2020
Q1 		$259K Buy
969
+207
+27% +$64K ﹤0.01% 1186
2019
Q4 		$247K Sell
762
-135
-15% -$39.1K ﹤0.01% 1318
2019
Q3 		$245K Sell
897
-67
-7% -$24.6K ﹤0.01% 1262
2019
Q2 		$514K Buy
964
+9
+0.9% +$4.51K ﹤0.01% 977
2019
Q1 		$481K Buy
955
+17
+2% +$10.1K ﹤0.01% 1052
2018
Q4 		$462K Sell
938
-211
-18% -$127K ﹤0.01% 998
2018
Q3 		$1.05M Buy
1,149
+108
+10% +$92.2K 0.01% 814
2018
Q2 		$763K Buy
1,041
+168
+19% +$194K ﹤0.01% 862
2018
Q1 		$1.39M Sell
873
-533
-38% -$687K 0.01% 570
2017
Q4 		$1.26M Sell
1,406
-318
-18% -$188K 0.01% 598
2017
Q3 		$620K Buy
1,724
+329
+24% +$103K ﹤0.01% 777
2017
Q2 		$409K Buy
1,395
+139
+11% +$40.2K ﹤0.01% 901
2017
Q1 		$442K Buy
+1,256
New +$282K ﹤0.01% 906
2016
Q3 		– Sell
-721
Closed -$154K – 1257
2016
Q2 		$154K Buy
+721
New +$161K ﹤0.01% 1183

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Private Wealth Advisors's NKTR Position: Q3 2021 in Review

JP Morgan Private Wealth Advisors sold out of Nektar Therapeutics (NKTR) in Q3 2021, closing a stake of 726 shares — an estimated $187K sold.

JP Morgan Private Wealth Advisors first reported a position in NKTR in Q2 2016 and held it in 19 quarters. The position peaked at $1.39M in Q1 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Nektar Therapeutics position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 726 Nektar Therapeutics shares in Q3 2021, an estimated $187K.
  • JP Morgan Private Wealth Advisors first reported a position in Nektar Therapeutics in Q2 2016 and held it in 19 quarters.
  • JP Morgan Private Wealth Advisors's Nektar Therapeutics position peaked at $1.39M in Q1 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.